Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Virus Activation/drug effects"'
Autor:
Sophie Bouchat, Stéphane De Wit, Nadège Delacourt, Nathan Clumeck, Anna Kula, Marion Pardons, Carine Van Lint, Benoît Van Driessche, Francis Corazza, Véronique Avettand-Fenoel, Christine Rouzioux, Caroline Vanhulle, Olivier Rohr, Jean-Stéphane Gatot, Kabamba Kabeya, Gilles Darcis, Adeline Mélard
Publikováno v:
EMBO Molecular Medicine
ResearcherID
EMBO molecular medicine, 8 (2
EMBO Molecular Medicine, Wiley Open Access, 2015, 8 (2), pp.117-138. ⟨10.15252/emmm.201505557⟩
ResearcherID
EMBO molecular medicine, 8 (2
EMBO Molecular Medicine, Wiley Open Access, 2015, 8 (2), pp.117-138. ⟨10.15252/emmm.201505557⟩
Reactivation of HIV gene expression in latently infected cells together with an efficient cART has been proposed as an adjuvant therapy aimed at eliminating/decreasing the reservoir size. Results from HIV clinical trials using deacetylase inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b762f18ac9b54fc8de5a305cea527572
https://pubmed.ncbi.nlm.nih.gov/26681773
https://pubmed.ncbi.nlm.nih.gov/26681773
Autor:
Sara K. Nissen, Giuseppe Pantaleo, Maja A. Sommerfelt, Mariane H. Schleimann, Rikke Olesen, Anne Sofie Høgh Kølbæk Kjær, Christel R. Brinkmann, Kim Krogsgaard, Kersten K. Koelsch, William J. Hey-Cunningham, Paul W. Denton, Ole S. Søgaard, Nicolas Chomont, Rémi Fromentin, Mette E. Graversen, Steffen Leth, Martin Tolstrup, Thomas A Rasmussen, Lars Østergaard
Publikováno v:
Plos Pathogens, vol. 11, no. 9, pp. e1005142
Søgaard, O S, Graversen, M E, Leth, S, Olesen, R, Brinkmann, C R, Nissen, S K, Kjaer, A S, Schleimann, M H, Denton, P W, Hey-Cunningham, W J, Koelsch, K K, Pantaleo, G, Krogsgaard, K, Sommerfelt, M, Fromentin, R, Chomont, N, Rasmussen, T A, Østergaard, L J & Tolstrup, M 2015, ' The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo ', P L o S Pathogens, vol. 11, no. 9, e1005142, pp. 1-22 . https://doi.org/10.1371/journal.ppat.1005142
PLoS Pathogens, Vol 11, Iss 9, p e1005142 (2015)
Søgaard, O S, Graversen, M E, Leth, S, Olesen, R, Brinkmann, C R, Nissen, S K, Kjaer, A S, Schleimann, M H, Denton, P W, Hey-Cunningham, W J, Koelsch, K K, Pantaleo, G, Krogsgaard, K, Sommerfelt, M, Fromentin, R, Chomont, N, Rasmussen, T A, Østergaard, L J & Tolstrup, M 2015, ' The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo ', P L o S Pathogens, vol. 11, no. 9, e1005142, pp. 1-22 . https://doi.org/10.1371/journal.ppat.1005142
PLoS Pathogens, Vol 11, Iss 9, p e1005142 (2015)
UnlabelledPharmacologically-induced activation of replication competent proviruses from latency in the presence of antiretroviral treatment (ART) has been proposed as a step towards curing HIV-1 infection. However, until now, approaches to reverse HI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90ff5e3d2ca27a7ecdd7ba1489504abe
https://pubmed.ncbi.nlm.nih.gov/26645606
https://pubmed.ncbi.nlm.nih.gov/26645606
Autor:
George K. K. Lau, Wing-Yan Au, A. K. W. Lie, Yok-Lam Kwong, Yui-Hung Yueng, HY Zhang, Benjamin Cy Wong, Winnie W.W. Cheung, Nancy Leung, Raymond Liang, Chee-Kin Hui
Publikováno v:
Gut. 54:1597-1603
Background: The hepatic outcome of hepatitis B surface antigen (HBsAg) positive patients undergoing chemotherapy after withdrawal of pre-emptive lamivudine is unknown. Aims: To examine the occurrence of hepatitis B virus (HBV) reactivation after with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a74097af3aecca19296fd8ed09115bab
https://doi.org/10.1136/gut.2005.070763
https://doi.org/10.1136/gut.2005.070763
Publikováno v:
Molecular Cancer
Molecular Cancer, Vol 8, Iss 1, p 18 (2009)
Molecular Cancer, Vol 8, Iss 1, p 18 (2009)
Background EBV lytic cycle activators, such as phorbol esters, anti-immunoglobulin, transforming growth factor β (TGFβ), sodium butyrate, induce apoptosis in EBV-negative but not in EBV-positive Burkitt's lymphoma (BL) cells. To investigate the mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9853fa12f0d1b1c0bea1186e17cb3bcb
https://doi.org/10.1186/1476-4598-8-18
https://doi.org/10.1186/1476-4598-8-18
Autor:
Arsène Burny, Luiz Francisco Pianowski, Jean-Stéphane Gatot, Amina Ait-Ammar, Benoît Van Driessche, Christian Schwartz, Olivier Rohr, Michel Moutschen, Caroline Vanhulle, Gilles Darcis, Jorge Vila, Sophie Bouchat, B. Matija Peterlin, Carine Van Lint, Kabamba Kabeya, Nathan Clumeck, Stéphane De Wit, Lucio Gama, Koh Fujinaga, Nadège Delacourt, Francis Corazza, Anna Kula, Adeline Mélard, Thomas Cherrier, Christine Rouzioux
Publikováno v:
PLoS Pathogens, Vol 11, Iss 7, p e1005063 (2015)
PLoS Pathogens
PLoS Pathogens, Public Library of Science, 2015, 11 (7), pp.e1005063. ⟨10.1371/journal.ppat.1005063⟩
PLoS Pathogens, 2015, 11 (7), pp.e1005063. ⟨10.1371/journal.ppat.1005063⟩
PLoS pathogens, 11 (7
PLoS Pathogens
PLoS Pathogens, Public Library of Science, 2015, 11 (7), pp.e1005063. ⟨10.1371/journal.ppat.1005063⟩
PLoS Pathogens, 2015, 11 (7), pp.e1005063. ⟨10.1371/journal.ppat.1005063⟩
PLoS pathogens, 11 (7
The persistence of latently infected cells in patients under combinatory antiretroviral therapy (cART) is a major hurdle to HIV-1 eradication. Strategies to purge these reservoirs are needed and activation of viral gene expression in latently infecte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc51900091f2bc5ae792fbce2e17e228
https://doi.org/10.1371/journal.ppat.1005063
https://doi.org/10.1371/journal.ppat.1005063
Autor:
Bayliss, G. J., Wolf, Hans J.
Immobilization of Raji cells on surface coated with anti-lymphocyte globulin (ALG) at low cell densities lead to the synthesis of Epstein-Barr virus (EBV) early antigen (EA) in up to 5% of the cells. At higher cell densities the percentage of antigen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f06322abb452640a5220a4015e380b74
